Table 2 Baseline clinical and health factors of patients initiating ART by coinfection in four high-burden hospitals in Addis Ababa, Ethiopia (September 2011 to December 2018), n = 646
Characteristics | n (%) of participants | |
|---|---|---|
HIV Monoinfection | HIV Coinfection | |
CD4 cell count/mm3 (n = 602) | ||
 Median (IQR) | 181(97–310) | 183(87–318) |
  < 200 | 263(54.68) | 63(52.07) |
  200–350 | 129(26.82) | 34(28.10) |
  > 350 | 89(18.50) | 24(19.83) |
WHO staging (n = 639) | ||
  I & II | 248(48.72) | 57(43.85) |
  III & IV | 261(51.28) | 73(56.15) |
Functional status (n = 635) | ||
  Bedridden | 81(15.98) | 16(12.50) |
  Ambulatory | 26(5.12) | 8(6.25) |
  Working | 400(78.90) | 104(81.25) |
bTuberculosis (TB) presence at baseline | ||
 Yes | 168(32.71) | 17(13.71) |
 No | 346(67.32) | 107(86.29) |
Opportunistic infection (OI) at baseline, n = 514 | ||
 Yes | 201(39.11) | 74(56.06) |
  No | 313(60.89) | 58(43.94) |
Median hemoglobin (IQR) (n = 474) | 13(11.4–14.5) | 13.9(12.1–15.1) |
b Median AST (IQR) (n = 549) | 30.5(22–45) | 36(26–53.5) |
b Medina ALT (IQR) (n = 508) | 23(16–38) | 28(18–44) |
b Median Platelet (IQR) (n = 260) | 242(198–315) | 185(151–218) |